Genetic
Variation of ACTN3 and MSTN Genes in a Ccohort of Endurance
Arabian Horses
S. Almarzook1*,
A. Said Ahmed1, M. Reissmann1, G. A. Brockmann1
1Humboldt-University of Berlin, Faculty of Life
Sciences, Albrecht Daniel Thaer-Institute for Agricultural and Horticultural
Sciences, Department of Animal Breeding Biology and Molecular Genetics,
Invalidenstrasse 42, 10115 Berlin, Germany
The
corresponding author:
- Dr. Saria
Almarzook: almarzos@hu-berlin.de
ABSTRACT
Arabian horses are readily
distinguishable in form and features, and they are widely known for endurance capability.
This study is the first examining of endurance-related genes in Arabian horses born
and raised in Syria. The major objective was to identify genetic variation in
candidate genes that could potentially affect endurance traits and to associate
them with endurance phenotypes. The two genes Alpha-actinin skeletal muscle
isoform 3 (ACTN3) and Myostatin (MSTN) were sequenced.
Performance traits were available for 42 recorded Arabian horses from Syria performed
endurance racing over 40, 80, and 120 km distances. Based on the recorded mean
speeds, horses were grouped according to their
performance index into low and high performers.
The comparative sequencing revealed
a total of 13 variants in both studied genes, 12 variants in ACTN3 and
one variant in MSTN. General linear model analyses showed that none of
the analyzed variants has significant effect on any of the studied traits.
However, for ACTN3, we found a 5’ UTR variant (12:26511704G>A) that predicted to cause a gain of an E4BP4
transcription factor binding site, and a variant in the 3´ UTR
12:26524930T>C that predicted to cause the abrogation of two predicted miRNA
target sites (eca-miR-1296 and eca-miR-326) and thereby affect gene expression.
For MSTN, a 5’ UTR variant 18:66495696A>G is predicted to cause the
substitution of the transcription factor binding sites for HFH-1 and Sox-5 by
binding sites for HFH-3 and E4BP4.
Keywords: Endurance, candidate genes, transcription
factor binding site, Arabian horse, Syria.
INTRODUCTION
Endurance played a vital role in the evolutionary history of human and other species, because it enabled them to survive and preserve their lives under different conditions (Maffetone 2010). In horses, endurance is a trait of great economic value. Humans invested in endurance to improve labor capability and athletic performance of horses. Nowadays, endurance performance is very important in the equestrian competitions. According to Bergero et al., (2005), the endurance performance of horses is identified as a low-intensity long-term trial. Most of the international equine endurance distances range between 30 and 500 km that can be run in one to five days. Different parameters were used to measure endurance performance. Endurance horses can achieve an average speed in endurance races exceeds 25 km/h in the last phase of the race (Nagy et al.,, 2012).
Heritability
estimates for mean speed in eight endurance horse breeds (including Arabian
horses) vary considerably between 0.16 and 0.40 at distances of 90 km and
≥ 120 km, respectively (Ricard & Touvais 2007). This makes the mean speed as one selection
parameter for endurance performance. Studies demonstrated differences in
biomarkers related to endurance performance including heart rate, lactate and
uric acid (Adamu et
al., 2012), physiology and metabolic performance (Bergero et al., 2005; Castejon et
al., 2006), morphological factors and gaiting variability
(Metayer et al., 2004; Cottin et al.,
2010), skeletal muscle fiber types (fast/low twitch
fibers), and fiber composition (Rivero et al., 1993; Rivero &
Barrey 2001). Pathways involved in endurance as a complex
quantitative trait provide a list of candidate genes to be tested for
association with endurance trait. There are approximately 230 candidate genes
suggested for athletic performance in humans (Bray et al., 2009; Schröder et
al., 2011). Recently, studies have tried to identify a
DNA profile specific to endurance performance in humans, but it is still under
consideration (Rankinen et al., 2016). In contrast to humans, in horses, only a
small set of genes related to racing performance has been genotyped until today
(Hill et
al., 2010a; Silva et al., 2015)
Genes of Interest
The
Alpha-actinin skeletal muscle isoform 3 (ACTN3) gene (ENSECAG00000018961) encodes the equine α-actinin
3 protein. The gene is
located between 26,511,750 and 26,524,992 bp on horse chromosome 12. ACTN3 is composed of 21 exons. ACTN3
is expressed mainly in the fast twitch muscle fibers (type 2 muscle fibers) which
are responsible for high speed and important for the maintenance of muscle
contraction (Yang et al., 2003; MacArthur &
North 2004; Sjöblom et al., 2008). The ACTN3 gene is highly conserved and
its mutation rate is lower than average (North 2008;
Fattahi & Najmabadi 2012) which reflects the importance of its function.
In humans, the homozygosity for a nonsense polymorphism (R577X), which converts
Arginine at position 577 of the protein into a stop codon, causes complete
deficiency of the fast skeletal muscle fiber protein α-actinin-3 (Mata et al., 2012; Orysiak et al.,
2014). In a study of endurance athletes, the XX
genotype was over-represented (Yang et
al., 2003). This suggest that ACTN3 variants may
contribute to enhancing the endurance performance (Yang et
al., 2003; Zanoteli et al., 2003). MacArthur et
al., (2008) supported this statement by mouse studies.
Their analysis of knockout mouse muscle showed a shift in the properties from
fast fibers towards slow fibers, increased activity of the metabolic enzymes
and better resistance to fatigue. In horses, ACTN3 is suggested to
affect muscle strength and insulin sensitivity which are related to endurance
performance in different horse breeds (Gu et al.,
2009; Thomas et al., 2014).
The
Myostatin (MSTN) gene
(ENSECAG00000021373) is located between 66,490,208 and 66,495,180 bp on horse
chromosome 18. MSTN comprises three
exons. MSTN encodes the growth differentiation factor 8 (GDF-8) which
belongs to the TGF-β protein family affecting growth, differentiation and
regulation of muscle proliferation as well as controlling the muscle fiber’s
growth (Carnac et
al., 2006). Additionally, MSTN is involved in
performance relevant functions such as regeneration of skeletal muscles, bone
formation, glucose metabolisms and adipocyte proliferation. In different
species, mutations which result in an inhibition of MSTN cause increased
muscle mass, for instance in Bully Whippet dogs and Belgian blue cattle (Mosher et
al., 2007). In horses, findings implied that MSTN
variants can be potential predictors of racing performance and morphological
traits (Gu et
al., 2009; Hill et al., 2010b; Tozaki et
al., 2011; Petersen et al., 2014; François et
al., 2016).
Horses, in
general, vary in their ability to perform endurance due to variability of
genetic background and morphological differences, health conditions, and
training programs. Arabian and Arabian-cross horses possess morphological and
physiological characters making them very suitable for endurance performance and
long distance riding under harsh conditions (Wood & Jackson 1989; Metzger et al.,
2015; USEF 2016). It
is strongly thought that adaptation to extreme endurance exercise is influenced
by genetic factors in this breed (Ricard et al., 2017).
Therefore, the
ultimate purpose of studying the racing genetics was to provide genetic
predictors of the horse’s potential for high racing ability. In this study, we
focus on Syrian Arabian horses which provide a valuable model to investigate
genetic variants in candidate genes for endurance in horses.
MATERIALS AND
METHODS
Animals and
endurance data
For this study, we sampled blood or hair from
42 endurance Arabian horses born in Syria
between 1994 and 2007. Samples were collected by state veterinarian according
to the animal welfare regulations set by the Syrian Ministry of Agriculture and
Agrarian Reform and the Syrian Arabian horse official authorities. The studied
horses performed endurance in official national events carried out in Syria
between 2001 and 2010. Mean speeds for short and medium endurance distances
based on international rules (Ricard & Touvais 2007) have been recorded. Based on mean speeds, 24
individuals were indicated as high endurance performers (18-25 km/h) and 18
were indicated as low endurance performers (6-16 km/h). Individuals who were excluded
from race due to lameness were included in our study as low performance horses
(Table 1). Weights (jockeys and their kits including lead weights) were optimized
to 75 Kg. 78.5% of the horses were born in the south of Syria (Damascus and
Dara) which suggests the homogeneity in geographical affiliation of the studied
group (supplementary Table S1).
Table
1: Arabian horses reported for endurance performance (high and low) for three distances
|
40 km |
80 km |
120 km |
|||
High performance |
Low performance |
High performance |
Low performance |
High performance |
Low performance |
|
7 |
5 |
7 |
11 |
10 |
2 |
|
SUM |
12 |
18 |
12 |
Table S1: Origins and sexes of 42 Syrian Arabian horses reported for
endurance performance
Region in Syria |
Number of
individuals |
|
Males |
Females |
|
Al Hasakah |
1 |
6 |
Damascus |
8 |
23 |
Dara |
- |
2 |
Hama |
1 |
- |
Hims |
1 |
- |
Total |
11 |
31 |
Genotyping of
the Candidate Genes
Promoters, exons and 3´ UTRs of two autosomal
genes (ACTN3 and
MSTN) were amplified using primers designed by using Primer3 online tool (Untergasser et
al., 2012). If the
intron was smaller than 350 bp, two exons were amplified using one primer pair
was designed based on the reference equine genome assembly EquCab2. Primers information with PCR product sizes are listed in the
supplementary Table S2.
Table S2: Information of gene
specific sequences, PCR product sizes and annealing temperature for the
analyzed fragments
Primers ID |
Sequence |
Product (bp) |
Annealing T˚ |
ACTN3 prom up |
AGG TTG AGC AGC TGG AAG G |
633 633 635 802 642 489 363 400 645 482 462 417 774 547 1052 |
59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 |
ACTN3 prom low |
CTG
TTC CAT ATA CTC GCC GC |
||
ACTN3 Exon1 up |
CTT
TCC CAA GGT CAC ACA GC |
||
ACTN3 Exon1 low |
TCC
CCT TGT CAC CCT AAA CC |
||
ACTN3 Exon2-3 up |
ACT
AGA GCT CAG GGA GGG AA |
||
ACTN3 Exon2-3 low |
TGT
GAG GCA TGG GTG GTT AT |
||
ACTN3 Exon4-5 up |
GAT CTG AAC CCG TGA AGC TG |
||
ACTN3 Exon4-5 low |
CAT
TAC CAG ACT TGC GCC AT |
||
ACTN3 Exon6-7 up |
TGG
TAA TGA AGG GCC TCA CA |
||
ACTN3 Exon6-7 low |
GGG
ACC AAT ATG CTC CCA GA |
||
ACTN3 Exon8 up |
CAG
GGA AGA AGA CAC TGG GT |
||
ACTN3 Exon8 low |
CTC CCT GTG TGA TGC CCT TA |
||
ACTN3 Exon9 up |
CTT TGC ATG GGT CCA GGT TT |
||
ACTN3 Exon9 low |
GAG CTT GGA TGG GCA GAA AG |
||
ACTN3 Exon10 up |
GAG ATG GGT GGA TGA GGT GA |
||
ACTN3 Exon10 low |
CCA
TCA CGG TTC ACC CAT TG |
||
ACTN3 Exon11 up |
ATC
AAC TTC AAC ACG CTG CA |
||
ACTN3 Exon11 low |
CCT TTG GAC ACC TGC TAT GC |
||
ACTN3 Exon12 up |
TAT
CAC ACT AGC GCC TCA GG |
||
ACTN3 Exon12 low |
GGG
ACA AGT GAT GAT GGG GA |
||
ACTN3 Exon13-14 up |
GCA GGC AAG GAG GAA ATC TG |
||
ACTN3 Exon13-14low |
AGC
TTC CCT GTC ATC CCA TC |
||
ACTN3 Exon15 up |
AAA GCG CCA GTT CTT GAG TG |
||
ACTN3 Exon15 low |
TGA GGT TTC AGG GTG GCT AG |
||
ACTN3 Exon16-17 up |
GTA
AAT GGT GCA CTG ACC CC |
||
ACTN3 Exon16-17low |
TTA
GAC TGC TCT GTG ACC GG |
||
ACTN3 Exon18-19 up |
AAC
CTC CAG ATG CGG ACA G |
||
ACTN3 Exon18-19low |
GCG TGA TGA GGA GGA AGT GA |
||
ACTN3 Exon20-21 up |
TCT GTG TGA CTC CAA AGC CT |
||
ACTN3 Exon20-21low |
TGT TCC CTT CCA CGG TGT AA |
||
MSTN prom up |
TGC CCT GGT AAT AAC AAT GAA GA |
1200 682 878 801 |
58 58 59 59 |
MSTN prom low |
TGC
CTG TAC AGT CTG AGA GA |
||
MSTN Exon1 up |
CTG GTG TGG CAA GTT GTC TC |
||
MSTN Exon1 low |
TGC
AGC AGA TTT CAG TCT CA |
||
MSTN Exon2 up |
GTT
CCT CCA CGG TGT CTC TT |
||
MSTN Exon2 low |
TTA
TTG GGT ACA GGG CTG CC |
||
MSTN Exon3 up |
AAC AAG CGT GAA GAG AGG GA |
||
MSTN Exon3 low |
AAT TGT GAG GGG AAG GCC TT |
Allele Frequency of the Identified Variants
Genes were initially sequenced in 10 endurance
Arabian horses which belong to two sub cohorts of high (n=5) and low
performance horses (n=5). PCR products were sequenced using the ABI PRISM 310
sequencer (Applied Biosystems). Sequences were edited using the Sequence
Scanner v2.0 (Applied Biosystems 2012, USA) as well as the BioEdit software (Hall 1999). The multiple sequence alignments were done using
Clustal Omega package (Sievers &
Higgins 2014).
The genomic positions of the identified
sequence variants were determined according to the Equus
caballus genome assembly EquCab2
(GCA_000002305.1) and the protein sequence that are available in Ensembl,
Release 90, 2017.
The Variant Effect Predictor toolset (Ensembl)
was used to determine functional consequences and novelty of the identified
variants. Furthermore, we checked both of the transcription factor binding
sites (TFBSs) within promoter regions using ConSite online toolset
(http://consite.genereg.net) as well as miRNA target sites in the 5´ and 3´
UTRs using miRBase Database, Release 21, with filtering for Equus caballus
(Griffiths-Jones et
al., 2006; Griffiths-Jones et al., 2007).
For determining alleles and
genotypes frequencies after identifying the sequence variants and constructing
the haplotypes (manually) based on the common variants, we additionally
genotyped 32 Arabian horses for the autosomal genes variants with KASP
genotyping method. Reagents were obtained from KBioscience (UK), PCR was
performed on a StepOnePlus set, (Applied Biosystems, USA) based on a protocol
from Kreuzer et
al., (2013) (Table S3).
Genotype and allele frequencies were
determined by direct counting. A generalized linear model (GLM) was used to
estimate the association of the SNPs with endurance performance traits including
the mean speeds and the three distances (40, 80, 120 Km) in both performance
indices. The GLM was performed using SAS (version 9.3) with the three genotypes
of each SNP as independent variables and the endurance traits as the dependent
variable.
Table S3: The customized allele-specific PCR assays and primers for the important identified ACTN3 and MSTN in 32 Arabian horses
SNP |
Gene |
Primer A1 |
Primer A2 |
Primer C |
Temp |
18:66493737 |
MSTN |
TAT
TAA GTA ATC AGG TTA TAA TGC ACC AAA |
ATT AAG TAA TCA GGT TAT AAT GCA CCA AG |
CCA
GGA CTA TTT GAT AGC AGA GTC ATA AA |
57 |
18:66495696 |
MSTN |
ATT
CTT TCT ATT TCA AAT GTT TGC CTA AAT AAT |
CTT
TCT ATT TCA AAT GTT TGC CTA AAT AAC |
GAA
ATG TTA CTT CCT CAG AAA TTA AGA TTT |
57 |
12:26511704 |
ACTN3 |
GGG
GCC TCG TTA AGT AGC GT |
GGG
GCC TCG TTA AGT AGC GC |
CCC
CAT ATT TAG CGC GAA TCC GAT |
57 |
12:26515885 |
ACTN3 |
GAC
CCC TTG ACC TCT CCT CTT A |
GAC
CCC TTG ACC TCT CCT CTT T |
GAT
TTT GTG GAA GCG CAT CTT GCC TT |
57 |
12:26524894 |
ACTN3 |
GTT
CTC CAC GCA AGT AGG AGC |
GGT TCT CCA CGC AAG TAG GAG T |
TGG
GAT CAG CCA GAG GGA GCA A |
57 |
RESULTS
The comparative sequence analysis of
the candidate genes in the 10 endurance Arabian horses led to identify a total
of 13 allelic variants in both ACTN3 and MSTN. The five promising
SNPs (three SNPs in ACTN3 and two SNPs in MSTN) were genotyped
across the 42 horses (Table S3).
ACTN3
By sequencing the promoter and 21
exons with flanking intron regions of ACTN3 (approximately 8.979 bp), we
found 12 variants: one 5´ UTR variant, five intronic variants, four exonic
synonymous variants, and two 3´ UTR variants (Table 2). No change in the amino
acid was detected. Three ACTN3 variants were genotyped further in 32
horses which are 12:26511704G>A, 12:26515885A>T, 12:26524894T>C.
In general, the more frequent
variants were the intronic variant 12:26515885A>T (splice region variant),
and the exonic variant 12:26524717A>G (synonymous variant) but no significant
frequency differences have been detected between the high and low performance
groups. One variant in the 3´ UTR (12:26524930T>C) was analyzed for its
potential effect on miRNA binding (eca-miR-1296 and eca-miR-326). Additionally,
the TFBSs analysis of the ACTN3 5’ UTR 12:26511704G>A was predicted
to cause gaining of an E4BP4 binding site (Table 3).
MSTN
By sequencing the promoter and three
exons with their flanking intron of MSTN in 10 horses, one transition
was detected at 18:66495696A>G within the promoter region. The MSTN
promoter polymorphism 18:66495696A>G was genotyped in further 32 horses. The
alternative allele G frequencies of the variant 18:66495696A>G are listed in
Table 2.
The analysis of TFBSs of the MSTN
promoter substitution of A to G at the position 18:66495696 is predicted to
cause substitution of two binding sites for HFH-1 and Sox-5 by two binding
sites for HFH-3 and E4BP4 (Table 3).
Table 2. The detected variants in the autosomal genes ACTN3 and MSTN, their
locations and the mutated allele’s frequencies
Gene |
SNP position |
Reference> mutated allele |
Amino acid change and positions |
Variant effect |
SNP ID |
Frequency of the mutated allele in
Arabian horses |
|||
Sequenced individuals N=10 |
Total N=42 |
High performers N=24 |
Low performers N=18 |
||||||
ACTN3 |
12:26511704 |
G>A |
- |
5´ UTR |
I1 (Thomas et al., 2014) |
0.50 |
0.42 |
0.33 |
0.53 |
12:26515793 |
C>G |
- |
Intronic (I12) |
rs68947239 |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26515795 |
C>T |
- |
Intronic (I12) |
rs68947240 |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26515807 |
T>C |
- |
Intronic (I12) |
I4 (Thomas et al., 2014) |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26515885 |
A>T |
- |
splice region (I12) |
rs68947241 |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26515942 |
C>T |
Ile105Ile |
Synonymous (E3) |
rs68947242 |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26516020 |
G>C |
- |
splice region(I3) |
rs68947243 |
0.45 |
0.43 |
0.46 |
0.39 |
|
12:26519406 |
A>G |
Pro366Pro |
synonymous (E10) |
E3 (Thomas et al., 2014) |
0.60 |
- |
- |
- |
|
12:26524504 |
T>C |
Ala814Ala |
synonymous (E20) |
rs394353570 |
0.95 |
- |
- |
- |
|
12:26524717 |
A>G |
Leu858Leu |
synonymous (E21) |
E6 (Thomas et al., 2014) |
0.30 |
0.61 |
0.58 |
0.64 |
|
12:26524894 |
T>C |
917 |
3´ UTR |
rs396350893 |
0.70 |
0.39 |
0.42 |
0.36 |
|
12:26524930 |
T>C |
929 |
3´ UTR |
rs396948497 |
0.30 |
0.61 |
0.58 |
0.64 |
|
MSTN |
18:66495696 |
A>G |
- |
Upstream |
(Stefaniuk et al.,
2016) |
0.15 |
0.09 |
0.10 |
0.08 |
E:
Exon, I: Intron
Frequencies
were calculated after aligning the variants, and constructing the haplotypes of
ACTN3 common variants.
Table 3:. Potential
effects of variants within the untranslated and promoter regions of ACTN3
and MSTN genes on miRNA and transcription factor binding sites (TFBSs)
Gene |
Variant position |
Location of variant |
Effect of the allelic change |
|
miRNA gain/loss of binding |
TFBSs* gain/loss of binding |
|||
ACTN3 |
12:26511704G>A |
5 ´ UTR |
- |
E4BP4 [+] |
ACTN3 |
12:26524930T>C |
3 ´ UTR |
eca-miR-1296 [-] eca-miR-326 [-] |
- |
MSTN |
18:66495696A>G |
Promoter |
- |
HFH-1 [-] Sox-5 [-] HFH-3[+] E4BP4[+] |
*TFBSs:
transcription factor binding sites, [+]=gain, [-]=loss
DISCUSSION
Although ACTN3 is an
important functional gene previous studies found variants which infer possible
functional changes (Thomas et
al., 2014). If we underlay one mutation every 644 to 891 bp in horses (Orlando et al., 2013), we would expect 10 to 14 variants in the ACTN3
gene. In the current study in Syrian Arabian horses, we detected 12 variants,
which is consistent with this expectation assuming an average mutation rate.
The ACTN3 5’ UTR variant 12:26511704G>A showed significant
frequencies differences between four equine phenotypes including endurance,
sprint, pace, and strength. The A-allele is overrepresented in the strength
(Clydesdale and Shire breeds, frequency=77%) and pace horses (Standardbred
breed, frequency=69%), compared to sprint (Thoroughbreds, frequency=17%) and
endurance horses (American Arabian, 38%) (Thomas et
al., 2014). The A-allele frequency in our current study of Syrian Arabian
horses (frequency=42%) is consistent with their findings. The variant
12:26511704G>A is predicted to cause gain of a binding site for the E4
promoter–binding protein 4 (E4BP4), a basic leucine zipper transcription
factor. E4BP4 regulates circadian rhythm by competing for DNA binding with a
member of the related PAR family of basic leucine zipper transcription factors.
E4BP4, also known as nuclear factor interleukin 3 (NFIL3) is thought to affect
exercise in the skeletal muscles (Bottinelli
& Reggiani 2007). Based on findings by Thomas et al.,
(2014), the ACTN3 exonic variants 12:26515942C>T (Exon3),
12:26519406A>G (Exon10), and 12:26524717A>G (Exon21) are assigned to
three conserved domains (Calpomin homology, Spectrin repeats, and the two
EF-hands, respectively), which have an important role in calcium ion binding supporting
the protein structure (Djinovic-Carugo et
al., 2002; Parry & Squire 2005). The 3´ UTR variants 12:26524894T>C and
12:26524930T>C seems to have no direct effect on the gene function. No clear
ACTN3 allele frequency differences were detected in our study between
high and low endurance performance horses. However, all variants in the 5´ and
3´ UTR were analyzed for their potential effects on miRNA binding.
Interestingly, one variant in the 3´ UTR of ACTN3 (12:26524930T>C) is
located within two predicted miRNA target sites (eca-miR-1296 and eca-miR-326).
The variant C is responsible for abrogation of these miRNA sites, which might
affect their post-transcriptional regulation and consequently the gene
expression.
In the MSTN gene, the
promoter variant 18:66495696A>G has been previously reported in different
horse breeds including Arabian, Thoroughbred, Polish Konik and Hucul horses (Binns et al., 2010; Dall'Olio et al.,
2010; Hill et al., 2010c; Tozaki et al., 2012; Stefaniuk et
al., 2014). The G-allele has a frequency of 0.23 in Arabian horses in Poland (Stefaniuk et al., 2014). Furthermore, 18:66495696A>G is suggested
to be associated with height at withers in Arabian horses and Uruguayan Creolo
horses (Dall’Olio et
al., 2012; Stefaniuk et al., 2016). In the current study, the frequency of the
alternative allele G was 0.09, and it did not differ considerably between high
and low performing groups.
Different studies reported promoter
variants of the equine MSTN gene. Among those promoter variants,
18:66495826A>G was also found in
Hucul, Polish
Heavy Draft, and Thoroughbred horses (Stefaniuk et
al., (2014). Studies in Thoroughbred horses showed an
association between racing performance phenotypes and promoter insertion
polymorphisms (227 bp SINE insertion located at -373/-147 bp upstream of the
translation start codon ATG). Animals homozygous for the SINE insertion allele
were most frequent short distance racing, heterozygous allele carriers were
more frequent in horses performing at middle-distance, while homozygous
carriers for the wild type allele were most often found in long-distance
endurance races (Hill et
al., 2010c; Dall’Olio et al., 2014). The SINE insertion is suggested to affect the
MSTN gene expression (Santagostino et
al., 2015). None of the above promoter variants are
observed in the Syrian Arabian horses. Interestingly, the intronic variant
18:66493737T>C has been widely known for its strong positive association
with short racing distance, speed and body composition in different racehorse
breeds (e.g. Thoroughbred) (Binns et
al., 2010; Hill et al., 2010a; Hill et
al., 2010c; Tozaki et al., 2011; Hill et
al., 2012; Tozaki et al., 2012). In all examined Syrian Arabian horses of the current study, this
locus was homozygous for the reference genotype (TT). Homozygosity for the T
allele was also found in Arabian horses sampled in Poland (Stefaniuk et
al., 2016). In another study, a an unique haplotype was
found in the second exon (EU241341) present in 12 of 19 Arabian horses (Baron et al., 2012). In our Syrian Arabian horses, the three MSTN
exons were conserved and identical to the reference. As shown in our study, MSTN
exons were conserved in 96 Arabian horses from Poland (Stefaniuk et
al., 2016).
The TFBSs analysis of the MSTN
promoter substitution of A to G at the position 18:66495696 predicted to cause
a loss of the Helix factor hepatocyte nuclear
factor-3 homologue 1 (HFH-1) and the sex-determining
region SRY-box 5 (Sox-5) transcription factor binding sites (UniProt), as well as, gaining of both: Hepatocyte Nuclear Factor 3 Forkhead
Homolog 3 (HFH-3) and E4 promoter–binding protein 4 (E4BP4). HFH-1 is one of the nuclear factors that
share a conserved DNA-binding domain (winged helix domain). It is thought to
have an impact on the nerve and skeletal systems in mammals, particularly
during the early stages of the embryo development (Altaba et
al., 1993; Hong et al., 1999; Hoggatt et al., 2000). HFH-1 can act as inhibitor for the abundant protein found in
smooth muscle-specific promoters (Hoggatt et
al., 2000). Smooth muscles are not directly involved in
the athletic performance, but their contractions are regulating the internal
organs (e.g. blood vessels).
The Sox family of
transcription factors is involved in regulating cell development and tissue
regeneration (Sarkar & Hochedlinger 2013). The transcription factor Sox-5
(sex-determining region SRY-box 5) is considered to be an enhancer of
chondrogenesis; as such it controls the correct development of the skeleton (Smits et al., 2001). Hepatocyte Nuclear Factor 3 Forkhead Homolog
3 (HFH-3 or FoxO1) is a member of the forkhead domain transcription factors
family, which are all expressed in skeletal muscle (Sanchez et
al., 2014) and involved in a wide range of cellular
functions including energy metabolism (Ogg et al.,
1997). HFH-3 has a vital role in development the sense of balance,
mediating the formation of fatty acids and glycerol to be consumed by muscle
cells under exercise, regulating of glucose metabolism in skeletal muscle, as
well as, muscle energy homeostasis (Furuyama et
al., 2003; Sanchez et al., 2014).
The correlation between endurance
traits and ACTN3 and MSTN genotypes was tested by GLM analysis,
and we found that none of the analyzed SNPs has
significant effect on the endurance traits. Only SNP 12:26511704G>A (located
in the 5´UTR of ACTN3) has marginally significant effect (0.04) on the
mean speed traits in both performance indices.
CONCLUSION
In the current study, we could not
detect any significant difference in allele frequencies of the 13 variants in both
genes ACTN3 and MSTN, therefore no differentiation
was detected between the high and low performance groups. But these variants
could influence the transcription factor binding sites (TFBSs) and the miRNAs.
Results could not show to which extent the possible effects of the changed
transcription binding factor sites have a direct influence on the endurance
performance of the Arabian horses.
However, this study contributes to
the knowledge of candidate genes that are related to endurance performance in
Syrian Arabian horses. Detection of the genetic background of the
endurance-related genes in Arabian horses is still a question to be answered.
This can be achieved if we test the association between polymorphisms of a
multi-gene panel in a larger group of endurance Arabian horses using more
endurance data. The information of the candidate genes variants could be
beneficial in improving selecting criteria and breeding programs in the future.
ACKNOWLEDGEMENTS
We
thank the Arabian horse office, the Syrian Ministry of Agriculture and Agrarian
Reform, the National commission for biotechnology in Syria, all Arabian horse
authorities and owners in Syria and abroad for their support and collaboration
on horse sampling and pedigrees identification. Samples were collected by state veterinarian
according to the animal welfare regulations set by the Syrian Ministry of
Agriculture and Agrarian Reform. This study was financially supported by the
IDB scholarship (MERIT).
REFERENCES
Adamu L., Adzahan N.M., Abdullah R.
& Ahmad B. (2012) Effects of speed, heart rate, lactate and uric acid on
the performance of arabian horses during a 120-km endurance race. IOSR Journal of Agriculture and Veterinary
Science 1, 1-4.
Altaba A.R., Prezioso V., Darnell J. & Jessell T. (1993)
Sequential expression of HNF-3β and HNF-3α by embryonic organizing
centers: the dorsal lip/node, notochord and floor plate. Mechanisms of development 44,
91-108.
Baron E., Lopes M., Mendonça D. & da Câmara Machado A. (2012)
SNP identification and polymorphism analysis in exon 2 of the horse myostatin
gene. Animal genetics 43, 229-32.
Bergero D., Assenza A. & Caola G. (2005) Contribution to our
knowledge of the physiology and metabolism of endurance horses. Livestock Production Science 92, 167-76.
Binns M., Boehler D. & Lambert D. (2010) Identification of the
myostatin locus (MSTN) as having a major effect on optimum racing distance in
the Thoroughbred horse in the USA. Animal
genetics 41, 154-8.
Bottinelli R. & Reggiani C. (2007) Skeletal muscle plasticity in health and disease: from genes to whole
muscle. Springer.
Bray M., Hagberg J., Perusse L., Rankinen T., Roth S., Wolfarth B.
& Bouchard C. (2009) The human gene map for performance and health-related
fitness phenotypes: the 2006-2007 update. Medicine+
Science in Sports+ Exercise 41,
35.
Carnac G., Ricaud S., Vernus B. & Bonnieu A. (2006) Myostatin:
biology and clinical relevance. Mini reviews
in medicinal chemistry 6,
765-70.
Castejon F., Trigo P., Muñoz A. & Riber C. (2006) Uric
acid responses to endurance racing and relationships with performance, plasma
biochemistry and metabolic alterations. Equine
Veterinary Journal 38, 70-3.
Cottin F., Metayer N., Goachet A., Julliand V., Slawinski J.,
Billat V. & Barrey E. (2010) Oxygen consumption and gait variables of
Arabian endurance horses measured during a field exercise test. Equine Veterinary Journal 42, 1-5.
Dall'Olio S., Fontanesi L., Nanni Costa L., Tassinari M., Minieri
L. & Falaschini A. (2010) Analysis of horse myostatin gene and
identification of single nucleotide polymorphisms in breeds of different
morphological types. BioMed Research
International 2010.
Dall’Olio S., Fontanesi L., Antonelli C., Nanni Costa L., Tassinari
M. & Falaschini A. (2012) Association study between a SNP of the myostatin
gene promoter and morphological traits in Uruguayan Creole horse. Proc. Soc. Ital. Sci. Vet 66, 412-4.
Dall’Olio S., Scotti E., Fontanesi L. & Tassinari M. (2014)
Analysis of the 227 bp short interspersed nuclear element (SINE) insertion of
the promoter of the myostatin (MSTN) gene in different horse breeds. Veterinaria italiana 50, 193-7.
Djinovic-Carugo K., Gautel M., Ylänne J. & Young P. (2002)
The spectrin repeat: a structural platform for cytoskeletal protein assemblies.
FEBS letters 513, 119-23.
Fattahi Z. & Najmabadi H. (2012) Prevalence of ACTN3 (the
athlete gene) R577X polymorphism in Iranian population. Iranian Red Crescent Medical Journal 14, 617.
François L., Fegraeus K.J., Eriksson S., Andersson L.S., Tesfayonas
Y.G., Viluma A., Imsland F., Buys N., Mikko S. & Lindgren G. (2016)
Conformation traits and gaits in the Icelandic horse are associated with genetic
variants in Myostatin (MSTN). Journal of
Heredity, esw031.
Furuyama T., Kitayama K., Yamashita H. & Nozomu M. (2003)
Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene
expression in skeletal muscle during energy deprivation. Biochemical Journal 375,
365-71.
Griffiths-Jones S., Grocock R.J., Van Dongen S., Bateman A. &
Enright A.J. (2006) miRBase: microRNA sequences, targets and gene nomenclature.
Nucleic acids research 34, D140-D4.
Griffiths-Jones S., Saini H.K., van Dongen S. & Enright A.J.
(2007) miRBase: tools for microRNA genomics. Nucleic acids research 36,
D154-D8.
Gu J., Orr N., Park S.D., Katz L.M., Sulimova G., MacHugh D.E.
& Hill E.W. (2009) A genome scan for positive selection in thoroughbred
horses. PLoS One 4, e5767.
Hall T.A. (1999) BioEdit: a user-friendly biological sequence
alignment editor and analysis program for Windows 95/98/NT. In: Nucleic acids symposium series, pp.
95-8.
Hill E., Gu J., McGivney B. & MacHugh D. (2010a) Targets of
selection in the Thoroughbred genome contain exercise‐relevant gene SNPs associated with elite racecourse performance. Animal genetics 41, 56-63.
Hill E.W., Fonseca R.G., McGivney B.A., Gu J., MacHugh D.E. &
Katz L.M. (2012) MSTN genotype (g. 66493737C/T) association with speed indices
in Thoroughbred racehorses. Journal of
Applied Physiology 112, 86-90.
Hill E.W., Gu J., Eivers S.S., Fonseca R.G., McGivney B.A.,
Govindarajan P., Orr N., Katz L.M. & MacHugh D. (2010b) A sequence
polymorphism in MSTN predicts sprinting ability and racing stamina in
thoroughbred horses. PLoS One 5, e8645.
Hill E.W., McGivney B.A., Gu J., Whiston R. & MacHugh D.E.
(2010c) A genome-wide SNP-association study confirms a sequence variant (g.
66493737C> T) in the equine myostatin (MSTN) gene as the most powerful
predictor of optimum racing distance for Thoroughbred racehorses. BMC genomics 11, 1.
Hoggatt A.M., Kriegel A.M., Smith A.F. & Herring B.P. (2000)
Hepatocyte nuclear factor-3 homologue 1 (HFH-1) represses transcription of
smooth muscle-specific genes. Journal of
Biological Chemistry 275,
31162-70.
Hong H.-K., Lass J.H. & Chakravarti A. (1999) Pleiotropic
skeletal and ocular phenotypes of the mouse mutation congenital hydrocephalus
(ch/Mf1) arise from a winged helix/forkhead transcription factor gene. Human molecular genetics 8, 625-37.
Kreuzer S., Reissmann M. & Brockmann G.A. (2013) Gene test to
elucidate the ETEC F4ab/F4ac receptor status in pigs. Veterinary microbiology 162,
293.
MacArthur D.G. & North K.N. (2004) A gene for speed? The
evolution and function of α‐actinin‐3. Bioessays 26, 786-95.
MacArthur D.G., Seto J.T., Chan S., Quinlan K.G., Raftery J.M.,
Turner N., Nicholson M.D., Kee A.J., Hardeman E.C. & Gunning P.W. (2008) An
Actn3 knockout mouse provides mechanistic insights into the association between
α-actinin-3 deficiency and human athletic performance. Human molecular genetics 17, 1076-86.
Maffetone P. (2010) The big
book of endurance training and racing. Skyhorse Publishing, Inc.
Mata X., Vaiman A., Ducasse A., Diribarne M., Schibler L. &
Guerin G. (2012) Genomic structure, polymorphism and expression of the horse
alpha-actinin-3 gene. Gene 491, 20-4.
Metayer N., Biau S., Cochet J. & Barrey E. (2004) Stduy of
locomotion and morphological factors in the performance of the horse
specialized in endurance tests. In: 30ème
journée de la recherche équine, 3 mars 2004., pp. 67-76. Les Haras
Nationaux Direction du Développement.
Metzger J., Karwath M., Tonda R., Beltran S., Águeda L., Gut
M., Gut I.G. & Distl O. (2015) Runs of homozygosity reveal signatures of
positive selection for reproduction traits in breed and non-breed horses. BMC genomics 16, 764.
Mosher D.S., Quignon P., Bustamante C.D., Sutter N.B., Mellersh
C.S., Parker H.G. & Ostrander E.A. (2007) A mutation in the myostatin gene
increases muscle mass and enhances racing performance in heterozygote dogs. PLoS genetics 3, e79.
Nagy A., Dyson S.J. & Murray J.K. (2012) A veterinary review of
endurance riding as an international competitive sport. The Veterinary Journal 194,
288-93.
North K. (2008) Why is α-actinin-3 deficiency so common in the
general population? The evolution of athletic performance. Twin Research and Human Genetics 11, 384-94.
Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum
H.A. & Ruvkun G. (1997) The Fork head transcription factor DAF-16
transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-9.
Orlando L., Ginolhac A., Zhang G., Froese D., Albrechtsen A.,
Stiller M., Schubert M., Cappellini E., Petersen B. & Moltke I. (2013)
Recalibrating Equus evolution using the genome sequence of an early Middle
Pleistocene horse. Nature 499, 74-8.
Orysiak J., Busko K., Michalski R., Mazur-Różycka J.,
Gajewski J., Malczewska-Lenczowska J., Sitkowski D. & Pokrywka A. (2014)
Relationship between ACTN3 R577X polymorphism and maximal power output in elite
Polish athletes. Medicina 50, 303-8.
Parry D.A. & Squire J.M. (2005) Fibrous proteins: Coiled-coils, collagen and elastomers. Gulf
Professional Publishing.
Petersen J.L., Valberg S.J., Mickelson J.R. & McCue M.E. (2014)
Haplotype diversity in the equine myostatin gene with focus on variants associated
with race distance propensity and muscle fiber type proportions. Animal genetics 45, 827-35.
Rankinen T., Fuku N., Wolfarth B., Wang G., Sarzynski M.A., Alexeev
D.G., Ahmetov I.I., Boulay M.R., Cieszczyk P. & Eynon N. (2016) No evidence
of a common DNA variant profile specific to world class endurance athletes. PLoS One 11, e0147330.
Ricard A., Robert C., Blouin C., Baste F., Torquet G., Morgenthaler
C., Rivière J., Mach N., Mata X. & Schibler L. (2017) Endurance exercise
ability in the horse: a trait with complex polygenic determinism. Frontiers in genetics 8, 89.
Ricard A. & Touvais M. (2007) Genetic parameters of performance
traits in horse endurance races. Livestock
Science 110, 118-25.
Rivero J.-L.L. & Barrey E. (2001) Heritabilities and genetic
and phenotypic parameters for gluteus medius muscle fibre type composition,
fibre size and capillaries in purebred Spanish horses. Livestock Production Science 72,
233-41.
Rivero J., Serrano A.L., Henckel P. & Aguera E. (1993) Muscle
fiber type composition and fiber size in successfully and unsuccessfully
endurance-raced horses. Journal of
Applied Physiology 75, 1758-66.
Sanchez A.M., Candau R.B. & Bernardi H. (2014) FoxO
transcription factors: their roles in the maintenance of skeletal muscle
homeostasis. Cellular and molecular life
sciences 71, 1657-71.
Santagostino M., Khoriauli L., Gamba R., Bonuglia M., Klipstein O.,
Piras F.M., Vella F., Russo A., Badiale C. & Mazzagatti A. (2015)
Genome-wide evolutionary and functional analysis of the Equine Repetitive
Element 1: an insertion in the myostatin promoter affects gene expression. BMC genetics 16, 126.
Sarkar A. & Hochedlinger K. (2013) The sox family of
transcription factors: versatile regulators of stem and progenitor cell fate. Cell stem cell 12, 15-30.
Schröder W., Klostermann A. & Distl O. (2011) Candidate
genes for physical performance in the horse. The Veterinary Journal 190,
39-48.
Sievers F. & Higgins D.G. (2014) Clustal omega. Current Protocols in Bioinformatics,
3.13. 1-3.. 6.
Silva M.S., Bolani W., Alves C.R., Biagi D.G., Lemos Jr J.R., da
Silva J.L., de Oliveira P.A., Alves G.B., de Oliveira E.M. & Negrão
C.E. (2015) Elimination of Influences of the ACTN3 R577X Variant on Oxygen
Uptake by Endurance Training in Healthy Individuals. IJSPP 10.
Sjöblom B., Salmazo A. & Djinović-Carugo K. (2008)
α-Actinin structure and regulation. Cellular
and molecular life sciences 65,
2688-701.
Smits P., Li P., Mandel J., Zhang Z., Deng J.M., Behringer R.R., De
Crombrugghe B. & Lefebvre V. (2001) The transcription factors L-Sox5 and
Sox6 are essential for cartilage formation. Developmental
cell 1, 277-90.
Stefaniuk M., Kaczor U., Augustyn R., Gurgul A., Kulisa M. &
Podstawski Z. (2014) Identification of a New Haplotype within the Promoter
Region of the MSTN Gene in Horses from Five of the most Common Breeds in
Poland. Folia biologica 62, 219-22.
Stefaniuk M., Ropka-Molik K., Piórkowska K., Kulisa M. &
Podstawski Z. (2016) Analysis of polymorphisms in the equine MSTN gene in
Polish populations of horse breeds. Livestock
Science 187, 151-7.
Thomas K.C., Hamilton N.A., North K.N. & Houweling P.J. (2014)
Sequence analysis of the equine ACTN3 gene in Australian horse breeds. Gene 538, 88-93.
Tozaki T., Hill E., Hirota K., Kakoi H., Gawahara H., Miyake T.,
Sugita S., Hasegawa T., Ishida N. & Nakano Y. (2012) A cohort study of
racing performance in Japanese Thoroughbred racehorses using genome information
on ECA18. Animal genetics 43, 42-52.
Tozaki T., Sato F., Hill E.W., Miyake T., Endo Y., Kakoi H.,
Gawahara H., Hirota K.-i., Nakano Y. & Nambo Y. (2011) Sequence variants at
the myostatin gene locus influence the body composition of Thoroughbred horses.
Journal of Veterinary Medical Science
73, 1617-24.
UniProt The Universal Protein Resource. The UniProt Consortium, http://www.uniprot.org.
Untergasser A., Cutcutache I., Koressaar T., Ye J., Faircloth B.C.,
Remm M. & Rozen S.G. (2012) Primer3—new capabilities and interfaces. Nucleic acids research 40, e115-e.
USEF (2016) RULE BOOK. United
States Equestrian Federation,, 4047 Iron Works Parkway Lexington, KY 40511
Wood C.H. & Jackson S.G. (1989) Horse Judging Manual. University of Kentucky Cooperative Extension
Service.
Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H.,
Easteal S. & North K. (2003) ACTN3 genotype is associated with human elite
athletic performance. The American
Journal of Human Genetics 73,
627-31.
Zanoteli E., Lotuffo R.M., Oliveira A.S., Beggs A.H., Canovas M.,
Zatz M. & Vainzof M. (2003) Deficiency of muscle α-actinin-3 is
compatible with high muscle performance. Journal
of molecular neuroscience 20,
39-42.
Copyright (c) 2019 Global Journal of Animal Scientific Research. All rights
reserved.